BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2183789)

  • 1. Nitric oxide is inactivated by the bacterial pigment pyocyanin.
    Warren JB; Loi R; Rendell NB; Taylor GW
    Biochem J; 1990 Mar; 266(3):921-3. PubMed ID: 2183789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [KMnO4-induced change in the chemiluminescence of Pseudomonas aeruginosa cells after their preliminary interaction with pyocyanine].
    Gusev MV; Parkhomenko IM; Ushakova NA
    Mikrobiologiia; 1980; 49(6):911-8. PubMed ID: 6782436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM; Ferrige AG; Moncada S
    Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
    Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quenching of singlet oxygen by pyocyanin and related phenazines.
    Reszka KJ; Bilski PJ; Britigan BE
    Photochem Photobiol; 2010; 86(4):742-6. PubMed ID: 20408986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premature cellular senescence induced by pyocyanin, a redox-active Pseudomonas aeruginosa toxin.
    Muller M
    Free Radic Biol Med; 2006 Dec; 41(11):1670-7. PubMed ID: 17145555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium.
    Myers PR; Wright TF; Tanner MA; Ostlund RE
    J Lab Clin Med; 1994 Nov; 124(5):672-83. PubMed ID: 7964125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenazine pyocyanin is a terminal signalling factor in the quorum sensing network of Pseudomonas aeruginosa.
    Dietrich LE; Price-Whelan A; Petersen A; Whiteley M; Newman DK
    Mol Microbiol; 2006 Sep; 61(5):1308-21. PubMed ID: 16879411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.
    Gryglewski RJ; Palmer RM; Moncada S
    Nature; 1986 Apr 3-9; 320(6061):454-6. PubMed ID: 3007998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
    Ignarro LJ; Byrns RE; Buga GM; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of T cell inhibition by the Pseudomonas aeruginosa phenazine pigment pyocyanine.
    Nutman J; Berger M; Chase PA; Dearborn DG; Miller KM; Waller RL; Sorensen RU
    J Immunol; 1987 May; 138(10):3481-7. PubMed ID: 2952718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
    Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
    Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
    Ignarro LJ; Harbison RG; Wood KS; Kadowitz PJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of pyocyanin, a cytotoxic product from Pseudomonas aeruginosa, by microperoxidase 11 and hydrogen peroxide.
    Reszka KJ; O'Malley Y; McCormick ML; Denning GM; Britigan BE
    Free Radic Biol Med; 2004 Jun; 36(11):1448-59. PubMed ID: 15135182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of pyocyanin on the intensity of KMnO4-induced protein chemiluminescence].
    Ushakova NA; Parkhomenko IM
    Mikrobiologiia; 1980; 49(5):833-5. PubMed ID: 7442575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibility of detecting pyocyanine in Pseudomonas aeruginosa cells].
    Gusev MV; Ushakova NA
    Mikrobiologiia; 1980; 49(4):555-60. PubMed ID: 6774217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection.
    Usher LR; Lawson RA; Geary I; Taylor CJ; Bingle CD; Taylor GW; Whyte MK
    J Immunol; 2002 Feb; 168(4):1861-8. PubMed ID: 11823520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments.
    Nutman J; Chase PA; Dearborn DG; Berger M; Sorensen RU
    Isr J Med Sci; 1988; 24(4-5):228-32. PubMed ID: 3132436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pyocyanin and 1-hydroxyphenazine on in vivo tracheal mucus velocity.
    Munro NC; Barker A; Rutman A; Taylor G; Watson D; McDonald-Gibson WJ; Towart R; Taylor WA; Wilson R; Cole PJ
    J Appl Physiol (1985); 1989 Jul; 67(1):316-23. PubMed ID: 2759959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
    Blaise GA; Stewart DJ; Guérard MJ
    Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.